MedPath

Comparative study between Two Drugs for Regional Anaesthesia using Ultrasound Guided Nerve Blocks through PerineuralCatheter for Postoperative Analgesia in Upper limb Surgeries

Recruiting
Conditions
Other intraoperative and postprocedural complications and disorders of musculoskeletal system, not elsewhere classified,
Registration Number
CTRI/2020/06/025810
Lead Sponsor
Dr Syed Arafath Ahmed
Brief Summary

The proposed study is tocompare the effectiveness of two different local anaesthetic drugs (0.125%Bupivacaine and 0.2% Ropivacaine) in the Post- operative Period after anelectively posted Upper Limb Surgery in patients satisfying the inclusion andthe exclusion criteria

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
All
Target Recruitment
60
Inclusion Criteria

American Society of Anaesthesiologists(ASA) 1 and 2 Body Weight.

Exclusion Criteria
  • Age less than 18years and age more than 65 years.
  • Pregnant women Infection at the site of block Patients with coagulopathy History of allergy to local anaesthetic drugs Mental incapacity or language barrier precluding to informed consent Patient refusal Pre existing motor or sensory deficit in the operative limb Severe pulmonary pathology.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To assess the duration of postoperative analgesia using Visual Analogue Scale (VAS) in both groups Group R (Ropivacaine) and Group B (Bupivacaine).1.5 years
Secondary Outcome Measures
NameTimeMethod
To assess the degree of motor blockade in both groups1.5 years
To assess the time of first rescue analgesia required1.5 years

Trial Locations

Locations (1)

Sri Manakula Vinyagar Medical College and Hospital

🇮🇳

Pondicherry, PONDICHERRY, India

Sri Manakula Vinyagar Medical College and Hospital
🇮🇳Pondicherry, PONDICHERRY, India
Dr SYED ARAFATH AHMED
Principal investigator
9551087861
drahmed1216@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.